115 related articles for article (PubMed ID: 1204270)
1. The hypronosticon test in breast cancer.
Roberts JG; Williams M; Henk JM; Bligh AS; Baum M
Clin Oncol; 1975 Mar; 1(1):33-43. PubMed ID: 1204270
[No Abstract] [Full Text] [Related]
2. [Hydroxyproline in the diagnosis of bone metastases in breast cancer].
Gasser AB; Depierre D; Alberto P; Courvoisier B
Schweiz Med Wochenschr; 1977 Jul; 107(28):984-6. PubMed ID: 897640
[TBL] [Abstract][Full Text] [Related]
3. Urinary hydroxyproline excretion in carcinoma of the breast.
Cuschieri A; Felgate RA
Br J Exp Pathol; 1972 Jun; 53(3):237-41. PubMed ID: 5055709
[TBL] [Abstract][Full Text] [Related]
4. Relevance of hydroxyproline excretion to bone metastasis in breast cancer.
Gielen F; Dequeker J; Drochmans A; Wildiers J; Merlevede M
Br J Cancer; 1976 Sep; 34(3):279-85. PubMed ID: 974001
[TBL] [Abstract][Full Text] [Related]
5. Urinary hydroxyproline excretion in early and advanced breast cancer-a sequential study.
Cuschieri A
Br J Surg; 1973 Oct; 60(10):800-3. PubMed ID: 4748385
[No Abstract] [Full Text] [Related]
6. [Urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast cancer].
Ditzel J; Jordal R; Riskoer N
Ugeskr Laeger; 1968 Oct; 130(42):1766-71. PubMed ID: 5724711
[No Abstract] [Full Text] [Related]
7. Three-centre study on urinary hydroxyproline excretion in cancer of the breast.
Cuschieri A; Jarvie R; Taylor WH; Cant E; Furnival CM; Blumgart LH
Br J Cancer; 1978 Jun; 37(6):1002-5. PubMed ID: 678421
[TBL] [Abstract][Full Text] [Related]
8. The significance of hydroxyprolinuia for the proof of bone metastases of tumours.
Mirejovská E; Beska F; Pitronová M
Neoplasma; 1968; 15(4):433-8. PubMed ID: 5684467
[No Abstract] [Full Text] [Related]
9. Early morning hydroxyproline excretion in patients with breast cancer.
Powles TJ; Rosset G; Leese CL; Bondy PK
Cancer; 1976 Dec; 38(6):2564-6. PubMed ID: 1000483
[TBL] [Abstract][Full Text] [Related]
10. Free serum hydroxyproline and total urinary hydroxyproline for the detection of skeletal metastasis.
Gasser AB; Depierre D; Mermillod B; Courvoisier B
Br J Cancer; 1982 Mar; 45(3):477-81. PubMed ID: 7041941
[No Abstract] [Full Text] [Related]
11. [Hydroxyproline excretion as an index for the evaluation of metabolic bone changes].
Mühlbach R
Beitr Orthop Traumatol; 1966 Oct; 13(10):606-8. PubMed ID: 5977397
[No Abstract] [Full Text] [Related]
12. Hydroxyproline excretion in patients with breast cancer and response to treatment.
Powles TJ; Leese CL; Bondy PK
Br Med J; 1975 Apr; 2(5964):164-6. PubMed ID: 1125725
[TBL] [Abstract][Full Text] [Related]
13. Postabsorptive urinary hydroxyproline test in patients with metastatic bone disease from breast cancer.
Niell HB; Palmieri GM; Neely CL; McDonald MW
Arch Intern Med; 1981 Oct; 141(11):1471-3. PubMed ID: 7283558
[TBL] [Abstract][Full Text] [Related]
14. [On the excretion of bound hydroxyproline as an expression of changes in the organic cartilage and bone matrix].
Mühlbach R; Hirthe D; Lindenhayn K
Z Arztl Fortbild (Jena); 1966 May; 60(10):597-602. PubMed ID: 5997685
[No Abstract] [Full Text] [Related]
15. Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
Stĕpán JJ; Mikulecký M; Bek V; Broulík P; Pacovský V
Neoplasma; 1989; 36(4):495-501. PubMed ID: 2770935
[TBL] [Abstract][Full Text] [Related]
16. Urinary hydroxyproline, serum alkaline phosphatase, calcium and phosphorus in patients with bone neoplasms.
Radom S; Zulawski M; Golebiowska D
Pol Med J; 1972; 11(4):809-14. PubMed ID: 4342776
[No Abstract] [Full Text] [Related]
17. [Urinary hydroxyproline and cancer of the breast].
Bellido V; Carda P; Mascías E
Rev Esp Oncol; 1983; 30(1):7-16. PubMed ID: 6679910
[No Abstract] [Full Text] [Related]
18. [Hydroxyprolinuria in relation to bone metastases in patients with breast cancer].
Rico Lenza H; Millán Núñez-Cortés J; Rodríguez Mora VI; Espinós Pérez D
Rev Esp Oncol; 1980; 27(1):61-6. PubMed ID: 7209108
[TBL] [Abstract][Full Text] [Related]
19. A biochemical approach to the staging of human breast cancer.
Coombes RC; Powles TJ; Gazet JC; Ford HT; Nash AG; Sloane JP; Hillyard CJ; Thomas P; Keyser JW; Marcus D; Zinberg N; Stimson WH; Neville AM
Cancer; 1977 Aug; 40(2):937-44. PubMed ID: 890676
[No Abstract] [Full Text] [Related]
20. Urinary hydroxyproline excretion in patients with cancer.
Guzzo CE; Pachas WN; Pinals RS; Krant MJ
Cancer; 1969 Aug; 24(2):382-7. PubMed ID: 5796782
[No Abstract] [Full Text] [Related]
[Next] [New Search]
